Comparison
3 Methylglutaconic Aciduria Type Viia C5676967 vs 3q13 Microdeletion Syndrome C2931338
Clinical comparison between 3 Methylglutaconic Aciduria Type Viia and 3q13 Microdeletion Syndrome for differential diagnosis and treatment planning.
3 Methylglutaconic Aciduria Type Viia C5676967
A rare inherited metabolic disorder affecting mitochondrial function. It typically appears in infancy with developmental delay, movement problems, and muscle weakness. Management focuses on supportive care and addressing specific symptoms.
3q13 Microdeletion Syndrome C2931338
A genetic disorder from missing material on chromosome 3q13, associated with developmental delays, intellectual disability, and various congenital features.
6 comparison axes
Onset
3 Methylglutaconic Aciduria Type Viia C5676967
0-2
3q13 Microdeletion Syndrome C2931338
Variable
Onset patterns differ
Severity
3 Methylglutaconic Aciduria Type Viia C5676967
severe
3q13 Microdeletion Syndrome C2931338
moderate
Different severity levels
Chronic
3 Methylglutaconic Aciduria Type Viia C5676967
Chronic
3q13 Microdeletion Syndrome C2931338
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria Type Viia C5676967
No
3q13 Microdeletion Syndrome C2931338
No
Different transmission
Body System
3 Methylglutaconic Aciduria Type Viia C5676967
metabolic
3q13 Microdeletion Syndrome C2931338
congenital
Same/different system
Category
3 Methylglutaconic Aciduria Type Viia C5676967
metabolic
3q13 Microdeletion Syndrome C2931338
genetic
Different category
Bottom line
3-methylglutaconic-aciduria-type-viia-C5676967 and 3q13-microdeletion-syndrome-C2931338 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylglutaconic Aciduria Type Viia C5676967 | 3q13 Microdeletion Syndrome C2931338 | Discriminating power |
|---|---|---|---|
| Developmental delay | Typically described from infancy with neurologic involvement. | Variable onset with intellectual disability and congenital features. | Moderate |
| Movement and muscle findings | Movement problems and muscle weakness are described. | Not specifically established in the supplied description. | Moderate |
| Congenital features | Not the principal pattern described. | Various congenital features may accompany developmental delay. | Moderate |
When to favor each condition
Choose 3 Methylglutaconic Aciduria Type Viia C5676967 when
Infancy-onset delay with weakness or movement problems
This pattern fits the described mitochondrial metabolic disorder.
Moderate
Organic-acid testing suggests 3-methylglutaconic aciduria
A biochemical abnormality supports further metabolic evaluation; it is not the complete diagnosis.
High
Clinical concern centers on inherited mitochondrial dysfunction
The supplied category is metabolic rather than a chromosomal deletion.
Moderate
Choose 3q13 Microdeletion Syndrome C2931338 when
Delay with intellectual disability and congenital anomalies
This combination better matches the described microdeletion syndrome.
Moderate
Testing shows missing material at chromosome 3q13
A confirmed copy-number change directly supports this diagnosis.
High
No metabolic clue and features appear congenital
Chromosomal evaluation is then more relevant than organic-acid disease.
Moderate
How key tests differ
| Test | 3 Methylglutaconic Aciduria Type Viia C5676967 | 3q13 Microdeletion Syndrome C2931338 | Interpretation |
|---|---|---|---|
| Urine organic acids | May show 3-methylglutaconic acid elevation; no cutoff is supplied. | Not expected to define the syndrome. | An abnormal result needs specialist review and is not itself a diagnosis. |
| Chromosomal microarray | Not expected to identify a causative 3q13 deletion. | May detect missing 3q13 material. | A confirmed deletion supports the right condition. |
| Targeted genetic evaluation | May seek a variant relevant to mitochondrial metabolism when indicated. | Primarily concerns chromosomal copy number. | The tests address different mechanisms and require clinician selection. |
Prognosis comparison
3 Methylglutaconic Aciduria Type Viia C5676967
- Outcome
- Described as severe and chronic; exact outcome is not established.
- Factors
- Onset, neurologic involvement, and supportive needs may influence course.
3q13 Microdeletion Syndrome C2931338
- Outcome
- Described as moderate and chronic; the individual range is not established.
- Factors
- Deletion findings, congenital features, and developmental support may matter.
Time frame: Generally lifelong, with infancy emphasized for the metabolic condition.
Prognosis requires specialist interpretation and should not be generalized.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic impairment | Delay, movement problems, and weakness are described. Developmental delay and intellectual disability are described. Both may be chronic, but individual severity is not established here. |
| Feeding or growth difficulty | Possible in severe infantile illness, but not specifically supplied. Not established from the supplied description. Do not assume this complication without clinical assessment. |
| Congenital anomalies | Not established as typical. Various congenital features are associated. Their type and severity require individual evaluation. |
Patient education highlights
- HighDifferent causes
One is a rare metabolic mitochondrial disorder; the other results from missing chromosome 3q13 material.
- HighTesting and diagnosis
Overlapping delay does not distinguish them. Diagnosis requires clinician-directed testing and interpretation.
- MediumCare
Management is supportive and individualized. No treatment dose or outcome can be inferred here.